Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about FDA approves Hemlibra for haemophilia A without factor VIII inhibitors
US Food and Drug Administration (FDA) has approved Hemlibra® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with haemophilia A without factor VIII inhibitors.
- Read more about Fragrance Ingredients Market to hit US$18.5 billion by 2024
The Fragrance Ingredients Market is set to grow from its current market value of more than $11.5 billion to over $18.5 billion by 2024; as reported in the latest study by Global Market Insights, Inc.
Growing penetration rate of international brands, rising demand for personal care products along with growth in cosmetics industry will drive overall fragrance ingredients market demand. These compounds are mixed with personal care products to improve aroma and give freshness to a product. Growing customer spending on beauty products including creams and perfumes supported by growing ageing population may boost industry growth.
- Read more about WHO FCTC opens 8th COP session to review progress, strengthen global fight against tobacco use
The Conference of Parties to the WHO Framework Convention for Tobacco Control (FCTC) opens its eighth session (COP 8), with a view to defining a roadmap for strengthening and expanding the scope of the landmark global health treaty.
- Read more about Indian government stands committed to ensure safety of vaccines
India has continued WHO engagement to support India maintain international quality surveillance for poliovirus detection in the country.

There have been reports in a section of the print media mentioning that bivalent oral polio vaccine supplied by a particular manufacturer had some quality issues. India was certified polio-free in March 2014 and continues to be so. India continues to remain vigilant against all three types of polioviruses. The last polio case due to wild poliovirus in the country was detected on 13 January 2011.
- Read more about Andhra Pradesh MedTech Zone lauded for making cost-effective medical devices
Continuing its efforts to promote medical technology in the country, Andhra Pradesh MedTech Zone (AMTZ) organised a mega business conference meeting ‘MedAsia Business Forum’ in the city.
- Read more about EMA and DG SANTE published joint action plan for boosting the development of medicines for children
The European Medicines Agency (EMA) and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) have published a joint action plan to support the development of medicines for children in Europe.
- Read more about FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients
The threat of cyber attacks is no longer theoretical. Cyber criminals and adversaries can inflict significant harm on networks through relatively simple methods, like emails or bugs known as malware. Even when medical devices are not being deliberately targeted, if these products are connected to a hospital network, such as radiologic imaging equipment, they may be impacted.
- Read more about RAYSEARCH RELEASES A NEW VERSION OF THE RAYCARE ONCOLOGY INFORMATION SYSTEM
RaySearch Laboratories AB (publ) has released RayCare 2B*, the latest version of the groundbreaking oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources.

[adsense:336x280:8701650588]
- Read more about FDA approves first treatment for advanced form of the second most common skin cancer
The U.S. Food and Drug Administration approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are not candidates for curative surgery or curative radiation. This is the first FDA approval of a drug specifically for advanced CSCC.
- Read more about FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma
U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing (NGS)-based test for minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL) or multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person’s bone marrow.